Obstetric Complications Common Among Women Who Develop Systemic Sclerosis
Researchers evaluated obstetric complications in women with a systemic sclerosis diagnosis vs the general obstetric population.
Systemic Sclerosis
Revised CRISS Developed to Improve dcSSc Study Outcome Measures
The performance of 5 core set measure in ACR-CRISS in recent trials was explored, and their ability to discern the active medication group from placebo in patients with diffuse cutaneous systemic sclerosis (dcSSc), was assessed.
Progressive ILD Trends in Systemic Sclerosis-Associated ILD
Close monitoring of patients with systemic sclerosis-associated interstitial lung disease and awareness of the variable course of progression is highly important in considering when to initiate treatment.
Data Support Safety, Efficacy of Abatacept in Early Diffuse Cutaneous Systemic Sclerosis
In this open-label extension study, researchers reported on the safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis.
Nintedanib Clinically Beneficial in Progression of Systemic Sclerosis-Associated Interstitial Lung Disease
Study authors analyzed the effects of nintedanib on changes in forced vital capacity and other measures of progression in systemic sclerosis-associated interstitial lung disease.
Antifibrotic Therapy Gets Orphan Drug Status for Systemic Sclerosis
ACE-1334 is a TGF-beta superfamily-based ligand trap designed to bind and inhibit TGF-beta 1 and 3 ligands.
British Society for Rheumatology Releases Consensus-Based Recommendations for Juvenile SSc Management
The British Society for Rheumatology released consensus-based recommendations for the management of juvenile systemic sclerosis.
Pulmonary Function Tests May Underdiagnose Interstitial Lung Disease in Juvenile Systemic Sclerosis
Study authors determined the performance of pulmonary screening vs HRCT in detecting interstitial lung disease in juvenile SSc.
Gastrointestinal Transit Abnormalities Associated With Severe GI Symptoms in Scleroderma
Researchers evaluated the contribution of abnormal GI transit to systemic sclerosis Medsger GI severity scores and/or UCLA GIT 2.0 symptoms.
Assessing the Long-Term Safety and Efficacy of Tocilizumab in Systemic Sclerosis
The long-term safety and efficacy of tocilizumab in patients with systemic sclerosis were assessed in an open-label study.
-
Loading...
-
Loading...
Next post in ACR Convergence 2020
